Surfactant Therapy in Full-term Neonates With Severe Respiratory Failure
1 From the Department of Pediatrics, Division of Neonatology, University of Toronto, and the Hospital for Sick Children, and Women's College Hospital, Toronto, Ontario, Canada
2 From the Department of Pediatrics, Division of Neonatology, University of Toronto, the Hospital for Sick Children, Toronto, Ontario, Canada
3 From the Department of Pediatrics, Division of Neonatology, University of Toronto, and the Women's College Hospital, Toronto, Ontario, Canada
Objective. In light of the paucity of published data on the use of surfactant in full-term infants with respiratory failure due to meconium aspiration syndrome and respiratory distress syndrome, we report our experience with this therapy. Our goal was to explore possible justification for randomized controlled trials of surfactant treatment in similar patients at an earlier, less severe stage of the disease.
Methods. Retrospective consecutive case series of 20 infants with severe meconium aspiration syndrome and 29 infants with severe respiratory distress syndrome who received bovine surfactant between March 1990 and December 1992 in three neonatal intensive care units in a regionalized setting. Outcome of treatment was assessed by comparing changes in several respiratory indices including the oxygenation index, between 4 and 6 hours and 1 and 3 hours before and after the first dose of surfactant. Differences were analyzed using analysis of variance for repeated measures, with treatment and time as co-variates.
Results. In the meconium aspiration group the mean oxygenation index decreased from 36 ± 12 at 1 to 3 hours presurfactant to 24 ± 14 at 1 to 3 hours postsurfactant (P < .001). In the patients with respiratory distress syndrome the mean oxygenation index fell from 30 ± 17 at 1 to 3 hours presurfactant to 12 ± 6 at 1 to 3 hours postsurfactant (P = .0001). Three of 20 patients with meconium aspiration syndrome and 3 of 29 patients with respiratory distress syndrome received extracorporeal membrane oxygenation.
Conclusions. Surfactant therapy in full-term infants with respiratory failure due to the meconium aspiration and respiratory distress syndromes is often effective in improving gas exchange. A randomized controlled trial of surfactant therapy at an earlier stage in the course of the illness should be performed.
Key Words: Pulmonary surfactant • respiratory distress syndrome • meconium aspiration syndrome • neonates
Submitted on January 26, 1993
Accepted on March 19, 1993
This article has been cited by other articles:
 |
|
 |
|
  T. D. Pawlik, N. F. M. Porta, R. H. Steinhorn, E. Ogata, and R.-A. O. deRegnier Medical and Financial Impact of a Neonatal Extracorporeal Membrane Oxygenation Referral Center in the Nitric Oxide Era Pediatrics, January 1, 2009; 123(1): e17 - e24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Engle and and the Committee on Fetus and Newborn Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate Pediatrics, February 1, 2008; 121(2): 419 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Davidson, P. R Knight, Z. Wang, P. R. Chess, B. A. Holm, T. A. Russo, A. Hutson, and R. H. Notter Surfactant alterations in acute inflammatory lung injury from aspiration of acid and gastric particulates Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L699 - L708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P J DAVIS and L S SHEKERDEMIAN Meconium aspiration syndrome and extracorporeal membrane oxygenation Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2001; 84(1): 1F - 3. [Full Text]
|
|
|
|
|
|
E. Herting, O. Gefeller, M. Land, L. van Sonderen, K. Harms, B. Robertson, and Members of the Collaborative European Multicenter Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection Pediatrics, November 1, 2000; 106(5): 957 - 964. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. HERTING, X. GAN, P. RAUPRICH, C. JARSTRAND, and B. ROBERTSON Combined Treatment with Surfactant and Specific Immunoglobulin Reduces Bacterial Proliferation in Experimental Neonatal Group B Streptococcal Pneumonia Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1862 - 1867. [Abstract] [Full Text]
|
|
|
|
|
|
B. C. C. Lam, F. FHKCP, and C. Y. Yeung Surfactant Lavage for Meconium Aspiration Syndrome: A Pilot Study Pediatrics, May 1, 1999; 103(5): 1014 - 1018. [Abstract] [Full Text]
|
|
|
|
|
|
T. F. Fok, M. Al-Essa, M. Dolovich, F. Rasid, and H. Kirpalani Nebulisation of surfactants in an animal model of neonatal respiratory distress Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1998; 78(1): 3F - 9. [Abstract] [Full Text]
|
|
|
|
|
|
G. M. Cleary, M. J. Antunes, D. A. Ciesielka, S. T. Higgins, A. R. Spitzer, and A. Chander Exudative Lung Injury Is Associated With Decreased Levels of Surfactant Proteins in a Rat Model of Meconium Aspiration Pediatrics, December 1, 1997; 100(6): 998 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Herting, B. Sun, C. Jarstrand, T. Curstedt, and B. Robertson Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1997; 76(1): 3F - 8. [Abstract] [Full Text]
|
|
